Literature DB >> 8984693

Functional antagonism: tolerance produced by inhaled beta 2 agonists.

D W Cockcroft1, V A Swystun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8984693      PMCID： PMC472666          DOI： 10.1136/thx.51.10.1051

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  27 in total

1.  Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma.

Authors:  B J O'Connor; S L Aikman; P J Barnes
Journal:  N Engl J Med       Date:  1992-10-22       Impact factor: 91.245

2.  Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthma.

Authors:  G J Gibson; J K Greenacre; P König; M E Conolly; N B Pride
Journal:  Br J Dis Chest       Date:  1978-07

3.  Bronchial reactivity to inhaled histamine: a method and clinical survey.

Authors:  D W Cockcroft; D N Killian; J J Mellon; F E Hargreave
Journal:  Clin Allergy       Date:  1977-05

4.  The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and the associated change in nonspecific bronchial responsiveness.

Authors:  C K Lai; O P Twentyman; S T Holgate
Journal:  Am Rev Respir Dis       Date:  1989-10

5.  Inhibition of hypertonic saline-induced bronchoconstriction by terfenadine and flurbiprofen. Evidence for the predominant role of histamine.

Authors:  J P Finnerty; C Wilmot; S T Holgate
Journal:  Am Rev Respir Dis       Date:  1989-09

6.  Dosage and time effects of inhaled budesonide on bronchial hyperreactivity.

Authors:  J Kraan; G H Koëter; T W van der Mark; M Boorsma; J Kukler; H J Sluiter; K De Vries
Journal:  Am Rev Respir Dis       Date:  1988-01

7.  Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline.

Authors:  A S Vathenen; A J Knox; B G Higgins; J R Britton; A E Tattersfield
Journal:  Lancet       Date:  1988-03-12       Impact factor: 79.321

Review 8.  Bronchial hyperresponsiveness is not bronchial hyperresponsiveness is not bronchial asthma.

Authors:  R Pauwels; G Joos; M Van der Straeten
Journal:  Clin Allergy       Date:  1988-07

9.  A method for comparing the peak intensity and duration of action of aerosolized bronchodilators using bronchoprovocation with methacholine.

Authors:  R C Ahrens; A C Bonham; G A Maxwell; M M Weinberger
Journal:  Am Rev Respir Dis       Date:  1984-06

10.  Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma.

Authors:  K F Kerrebijn; E E van Essen-Zandvliet; H J Neijens
Journal:  J Allergy Clin Immunol       Date:  1987-04       Impact factor: 10.793
View more
  20 in total

1.  Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism.

Authors:  D R Taylor; J M Drazen; G P Herbison; C N Yandava; R J Hancox; G I Town
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

Review 2.  Asthma--the changing face of drug therapy.

Authors:  J Legg; J Warner
Journal:  Indian J Pediatr       Date:  2000-02       Impact factor: 1.967

3.  Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma.

Authors:  M Delvaux; M Henket; L Lau; P Kange; P Bartsch; R Djukanovic; R Louis
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

Review 4.  Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma.

Authors:  E H Walters; J A Walters; P W Gibson
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 5.  Management of acute pediatric asthma.

Authors:  John C Carl; Carolyn M Kercsmar
Journal:  Curr Allergy Asthma Rep       Date:  2002-11       Impact factor: 4.806

Review 6.  β(2) -adrenoceptor agonists: current and future direction.

Authors:  Mario Cazzola; Luigino Calzetta; Maria Gabriella Matera
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

7.  Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.

Authors:  H J van der Woude; T H Winter; R Aalbers
Journal:  Thorax       Date:  2001-07       Impact factor: 9.139

8.  Asthma exacerbations during first therapy with long acting beta 2-agonists.

Authors:  C M Gerrits; R M Herings; H G Leufkens; J W Lammers
Journal:  Pharm World Sci       Date:  1999-06

9.  Effect of an inhaled glucocorticosteroid on mast cell and smooth muscle beta 2 adrenergic tolerance in mild asthma.

Authors:  D H Yates; M Worsdell; P J Barnes
Journal:  Thorax       Date:  1998-02       Impact factor: 9.139

10.  Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.

Authors:  D R Taylor; G I Town; G P Herbison; D Boothman-Burrell; E M Flannery; B Hancox; E Harré; K Laubscher; V Linscott; C M Ramsay; G Richards
Journal:  Thorax       Date:  1998-09       Impact factor: 9.139
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.